首页> 外文OA文献 >Title Does Definitive Local Therapy Offer Cure in Select HER2+ De Novo Metastatic Breast Cancer Patients Treated with Dual Anti-HER2 Blockade?

【2h】

Title Does Definitive Local Therapy Offer Cure in Select HER2+ De Novo Metastatic Breast Cancer Patients Treated with Dual Anti-HER2 Blockade?

机译：标题是否明确局部疗法提供治疗选择Her2 + de Novo转移性乳腺癌患者双重抗HER2封锁治疗？

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Luderve Rosier; Youth Wang; Jihyun Lee; Karen Daily;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Increased derived neutrophil-to-lymphocyte ratio and Breast Imaging-Reporting and Data System classification predict poor survival in patients with non-distant metastatic HER2+ breast cancer treated with neoadjuvant chemotherapy [J] . Yuyong Li, Yi Shao, Lishan Bai, Cancer Management and Research . 2018,第2016期

机译：衍生的中性粒细胞与淋巴细胞比例的增加以及乳房成像报告和数据系统的分类预测，使用新辅助化疗治疗的非远距离转移性HER2 +乳腺癌患者的生存率较低
2. Increased derived neutrophil-to-lymphocyte ratio and Breast Imaging-Reporting and Data System classification predict poor survival in patients with non-distant metastatic HER2+ breast cancer treated with neoadjuvant chemotherapy [J] . Yuyong Li, Yi Shao, Lishan Bai, Cancer Management and Research . 2018,第2013期

机译：衍生的中性粒细胞与淋巴细胞比例的增加以及乳房成像报告和数据系统的分类预测，使用新辅助化疗治疗的非远距离转移性HER2 +乳腺癌患者的生存率较低
3. Outcomes of HER2-positive non-metastatic breast cancer patients treated with anti-HER2 therapy without chemotherapy [J] . Nguy Susanna, Wu S. Peter, Oh Cheongeun, Breast cancer research and treatment. . 2021,第3期

机译：HER2阳性非转移性乳腺癌患者的结果，在没有化疗的情况下用抗HER2疗法治疗
4. Correlations between depressive symptoms and quality of life in metastatic breast cancer patients during chemotherapy [C] . Dragomir B.I., Campean A. European Association of Psychosomatic Medicine., Annual Meeting. . 2014

机译：化疗期间转移性乳腺癌患者抑郁症状与生活质量的相关性
5. Indirect Costs Associated with Human Epidermal Growth Factor Receptor Positive (HER2+) Metastatic Breast Cancer [D] . Wright, Phoebe. 2020

机译：与人表皮生长因子受体阳性（HER2 +）转移性乳腺癌相关的间接成本
6. BioPATH: A Biomarker Study in Asian Patients with HER2+ Advanced Breast Cancer Treated with Lapatinib and Other Anti-HER2 Therapy [O] . Sung-Bae Kim, In-Gu Do, Janice Tsang, 2019

机译：BioPATH：一项用拉帕替尼和其他抗HER2治疗方法治疗的亚洲HER2 +晚期乳腺癌患者的生物标志物研究
7. ERBB2 mRNA as a predictor in HER2-positive (HER2+)/hormone receptor-positive (HR+) metastatic breast cancer (BC) treated with HER2 blockade in combination with endocrine therapy (ET): A retrospective analysis of the ALTERNATIVE and SOLTI-PAMELA trials [O] . N. Chic, T. Pascual, F. Brasó-Maristany, 2019

机译：ERBB2 mRNA作为HER2阳性（HER2 +）/激素受体阳性（HR +）转移性乳腺癌（BC）的预测因子与HER2封闭与内分泌治疗（ET）组合处理（ET）：对替代品和索尔本米拉试验的回顾性分析

Title Does Definitive Local Therapy Offer Cure in Select HER2+ De Novo Metastatic Breast Cancer Patients Treated with Dual Anti-HER2 Blockade?

著录项

引文网络

相似文献

相关主题

期刊订阅